WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
The antiviral medication, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump's coronavirus infection. The results are from WHO's "Solidarity" trial, which evaluated the effects of four potential drug regimens

Full story is loading. Click here if it doesn't...